Maastricht 2017 Meeting Highlights Registration Programme Overview Exhibition Virtual Exhibition Hotels Satellite Meetings Visa Letter Application Star Alliance Travel Discount

10 - 12 February 2017, MECC Maastricht,The Netherlands.

This Meeting has been awarded 15 CME credits.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Medennium posterior chamber phakic intraocular lens implantion in patients with extremly high myopia

Poster Details

First Author: D. Dementiev RUSSIA

Co Author(s): A. Shipunova   M. Sysoeva   I. Ivanchikova              

Abstract Details


To analyze the visual outcomes and complications of the Medennium posterior chamber phakic intraocular lens implantation (MPL) in patients with extremely high myopia


Blue Eye” Centro di Chirurgia Oculare, Milano, Italy, “International Center for Ophthalmology”, Moscow, Russia


We reviewed 102 myopic eyes undergoing MPL implantation in which refractive errors ranged from -10.0 to -32.0 diopters (D). The mean follow-up period was 26.28±10.44 months. Autorefractometry, uncorrected distance visual acuity (UCVA), best corrected visual acuity (BCVA), optical biometry, intraocular pressure (IOP), OCT Visante, corneal endothelial cell (CEC) loss were measured


The mean SE changed from -16.75±6.11D to -1.25±0.82. The UCVA improved from 1.63±6.25 to 0.32±0.45. BCVA changed from 0.32±0.45 to 0.21±0.16. The mean distance between Crystalline lens and MPL 362,44±91 µm. No statistically CEC loss was induced by the lens implantation. No induced cataract, glaucoma, or inflammation were observed


The visual outcomes of the MPL implantation show efficacy, predictability and stability of results even in eyes with extremely high myopia

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a competing company

Back to Poster listing